GMED Covered Call Strategy
GMED (Globus Medical, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NYSE.
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives.
GMED (Globus Medical, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $11.55B, a trailing P/E of 21.66, a beta of 0.95 versus the broader market, a 52-week range of 54.15-101.4, average daily share volume of 1.7M, a public-listing history dating back to 2012, approximately 6K full-time employees. These structural characteristics shape how GMED stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.95 places GMED roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on GMED?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
GMED snapshot
As of August 14, 2026, spot at $85.91, ATM IV 29.40%, IV rank 4.19%, expected move 8.43%. The covered call on GMED below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on GMED specifically: GMED IV at 29.40% is on the cheap side of its 1-year range, which means a premium-selling GMED covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 8.43% (roughly $7.24 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GMED expiries trade a higher absolute premium for lower per-day decay. Position sizing on GMED should anchor to the underlying notional of $85.91 per share and to the trader's directional view on GMED stock.
GMED covered call setup
The GMED covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GMED at $85.91 on that close, the first option leg uses a $90.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GMED chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GMED shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $85.91 | long |
| Sell 1 | Call | $90.00 | $1.70 |
GMED covered call risk and reward
- Net Premium / Debit
- -$8,421.00
- Max Profit (per contract)
- $579.00
- Max Loss (per contract)
- -$8,420.00
- Breakeven(s)
- $84.21
- Risk / Reward Ratio
- 0.069
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
GMED covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on GMED. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$8,420.00 |
| $19.00 | -77.9% | -$6,520.59 |
| $38.00 | -55.8% | -$4,621.19 |
| $56.99 | -33.7% | -$2,721.78 |
| $75.99 | -11.6% | -$822.37 |
| $94.98 | +10.6% | +$579.00 |
| $113.97 | +32.7% | +$579.00 |
| $132.97 | +54.8% | +$579.00 |
| $151.96 | +76.9% | +$579.00 |
| $170.96 | +99.0% | +$579.00 |
When traders use covered call on GMED
Covered calls on GMED are an income strategy run on existing GMED stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
GMED thesis for this covered call
The market-implied 1-standard-deviation range for GMED extends from approximately $78.67 on the downside to $93.15 on the upside. A GMED covered call collects premium on an existing long GMED position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether GMED will breach that level within the expiration window. Current GMED IV rank near 4.19% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on GMED at 29.40%. As a Healthcare name, GMED options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GMED-specific events.
GMED covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GMED positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GMED alongside the broader basket even when GMED-specific fundamentals are unchanged. Short-premium structures like a covered call on GMED carry tail risk when realized volatility exceeds the implied move; review historical GMED earnings reactions and macro stress periods before sizing. Always rebuild the position from current GMED chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on GMED?
- A covered call on GMED is the covered call strategy applied to GMED (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With GMED stock at $85.91 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed GMED chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are GMED covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the GMED covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 29.40%), the computed maximum profit is $579.00 per contract and the computed maximum loss is -$8,420.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a GMED covered call?
- The breakeven for the GMED covered call priced on this page is roughly $84.21 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The GMED market-implied 1-standard-deviation expected move in the same options snapshot is approximately 8.43%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on GMED?
- Covered calls on GMED are an income strategy run on existing GMED stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current GMED implied volatility affect this covered call?
- GMED ATM IV is at 29.40% with IV rank near 4.19%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.